p53 expression in uveal malignant melanomas

Area of Science:

• Oncology
• Genetics
• Ophthalmology

Background:

• The p53 gene, located on chromosome 17p, is frequently altered in human cancers.
• Malignant melanoma is the most common intraocular neoplasm in adults.
• Aberrant p53 expression is a common hallmark of many cancers.

Purpose of the Study:

• To evaluate aberrant p53 expression in malignant melanoma, a common intraocular neoplasm.
• To investigate the potential role of p53 gene alterations in the development of uveal melanomas.

Main Methods:

• Immunohistochemistry was used to analyze 20 enucleation specimens, including ciliary body and choroidal melanomas, and choroidal nevi.
• The D07 anti-p53 antibody and MIB-1 monoclonal antibody were utilized to assess p53 expression and cell proliferation.
• Tumor types included spindle cell and mixed cell melanomas, as well as spindle cell nevi.

Main Results:

• Of 18 melanomas studied, 13 cases exhibited nuclear p53 staining.
• p53 positivity was observed in mixed cell type melanomas but not in spindle cell melanomas or choroidal nevi.
• No correlation was found between the MIB-1 labelling index (cell proliferation) and p53 immunoreactivity in mixed cell type melanomas.

Conclusions:

• p53 alterations may occur in uveal melanomas.
• p53 positivity was specifically found in malignant melanomas of the mixed cell type in this series.
• These findings suggest a potential involvement of p53 gene mutations in the pathogenesis of mixed cell type uveal melanomas.